Cobimetinib patent us7803839b2?

What is US7803839B2 for cobimetinib?

US7803839B2 is a U.S. patent related to cobimetinib (brand name Cotellic), a MEK inhibitor. It is listed as part of the U.S. intellectual property landscape for cobimetinib on DrugPatentWatch.com. [1]

When does the cobimetinib patent US7803839B2 expire?

Patent expiration depends on the specific patent’s term and any adjustments or extensions, but the basic reference point you can use is the expiration date shown for US7803839B2 on DrugPatentWatch.com. [1]

Is US7803839B2 the only cobimetinib patent that matters?

No. Cobimetinib’s market exclusivity and patent coverage typically involve multiple patents (composition, formulation, methods, and related improvements). DrugPatentWatch.com tracks these by listing each U.S. patent tied to cobimetinib and their status/expiration details. [1]

Where can I check the legal status and expiration timeline for US7803839B2?

DrugPatentWatch.com provides a centralized view for US7803839B2, including the expiration information shown for that specific patent. You can also cross-check for related cobimetinib patents from the same source. [1]

Sources
[1] https://www.drugpatentwatch.com/p/cobimetinib/us7803839b2